Literature DB >> 19223538

Activation of ribosomal RNA transcription by hepatitis C virus involves upstream binding factor phosphorylation via induction of cyclin D1.

Santanu Raychaudhuri1, Vanessa Fontanes, Bhaswati Barat, Asim Dasgupta.   

Abstract

Hepatitis C virus (HCV) causes chronic infection in humans leading to liver cirrhosis and hepatocellular carcinoma. rRNA transcription, catalyzed by RNA polymerase I (Pol I), plays a critical role in ribosome biogenesis, and changes in Pol I transcription rate are associated with profound alterations in the growth rate of the cell. Because rRNA synthesis is intimately linked to cell growth and frequently up-regulated in many cancers, we hypothesized that HCV might have the ability to activate rRNA synthesis in infected cells. We show here that rRNA promoter-mediated transcription is significantly (10- to 12-fold) activated in human liver-derived cells following infection with type 2 JFH-1 HCV or transfection with the subgenomic type 1 HCV replicon. Further analysis revealed that HCV nonstructural protein 5A (NS5A) was responsible for activation of rRNA transcription. Both the NH(2)-terminal amphipathic helix and the polyproline motifs of NS5A seem to be essential for rRNA transcription activation. The NS5A-dependent activation of rRNA transcription seems to be due to hyperphosphorylation and consequent activation of upstream binding factor (UBF), a Pol I DNA binding transcription factor. We further show that hyperphosphorylation of UBF occurs as a result of up-regulation of both cyclin D1 and cyclin-dependent kinase 4 by the HCV NS5A polypeptide. These results suggest that the endoplasmic reticulum-associated NS5A is able to transduce signals into the nucleoplasm via UBF hyperphosphorylation leading to rRNA transcription activation. These results could, at least in part, explain a mechanism by which HCV contributes to transformation of liver cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223538      PMCID: PMC2650774          DOI: 10.1158/0008-5472.CAN-08-3468

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Rb and p130 regulate RNA polymerase I transcription: Rb disrupts the interaction between UBF and SL-1.

Authors:  K M Hannan; R D Hannan; S D Smith; L S Jefferson; M Lun; L I Rothblum
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

2.  PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.

Authors:  Cheng Zhang; Lucio Comai; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

3.  Phosphatidylinositol 3-kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients.

Authors:  Martyn J James; Joost C B M Zomerdijk
Journal:  J Biol Chem       Date:  2003-12-19       Impact factor: 5.157

4.  Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein.

Authors:  H D Wang; A Trivedi; D L Johnson
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

5.  Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.

Authors:  T Fukuma; N Enomoto; F Marumo; C Sato
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

6.  Epidermal growth factor enhances cellular TATA binding protein levels and induces RNA polymerase I- and III-dependent gene activity.

Authors:  Shuping Zhong; Cheng Zhang; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

7.  Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner.

Authors:  M Majumder; A K Ghosh; R Steele; R Ray; R B Ray
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.

Authors:  N Arima; C Y Kao; T Licht; R Padmanabhan; Y Sasaguri; R Padmanabhan
Journal:  J Biol Chem       Date:  2001-01-19       Impact factor: 5.157

9.  Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication.

Authors:  Menashe Elazar; Kwang Ho Cheong; Ping Liu; Harry B Greenberg; Charles M Rice; Jeffrey S Glenn
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

10.  Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture.

Authors:  Keril J Blight; Jane A McKeating; Joseph Marcotrigiano; Charles M Rice
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

View more
  11 in total

Review 1.  Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma.

Authors:  X Xie; P Guo; H Yu; Y Wang; G Chen
Journal:  Oncogene       Date:  2017-09-25       Impact factor: 9.867

2.  Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.

Authors:  Takahiro Masaki; Ryosuke Suzuki; Mohsan Saeed; Ken-ichi Mori; Mami Matsuda; Hideki Aizaki; Koji Ishii; Noboru Maki; Tatsuo Miyamura; Yoshiharu Matsuura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

3.  Splicing factor 2-associated protein p32 participates in ribosome biogenesis by regulating the binding of Nop52 and fibrillarin to preribosome particles.

Authors:  Harunori Yoshikawa; Wataru Komatsu; Toshiya Hayano; Yutaka Miura; Keiichi Homma; Keiichi Izumikawa; Hideaki Ishikawa; Naoki Miyazawa; Hiroyuki Tachikawa; Yoshio Yamauchi; Toshiaki Isobe; Nobuhiro Takahashi
Journal:  Mol Cell Proteomics       Date:  2011-05-02       Impact factor: 5.911

4.  Arbovirus detection in insect vectors by rapid, high-throughput pyrosequencing.

Authors:  Kimberly A Bishop-Lilly; Michael J Turell; Kristin M Willner; Amy Butani; Nichole M E Nolan; Shannon M Lentz; Arya Akmal; Al Mateczun; Trupti N Brahmbhatt; Shanmuga Sozhamannan; Chris A Whitehouse; Timothy D Read
Journal:  PLoS Negl Trop Dis       Date:  2010-11-09

5.  The HBx oncoprotein of hepatitis B virus potentiates cell transformation by inducing c-Myc-dependent expression of the RNA polymerase I transcription factor UBF.

Authors:  Pallavi Rajput; Surendra Kumar Shukla; Vijay Kumar
Journal:  Virol J       Date:  2015-04-14       Impact factor: 4.099

6.  Human papillomavirus 16 oncoprotein E7 stimulates UBF1-mediated rDNA gene transcription, inhibiting a p53-independent activity of p14ARF.

Authors:  Isabelle Dichamp; Paule Séité; Gérard Agius; Alice Barbarin; Agnès Beby-Defaux
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

7.  Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among Paramyxovirinae matrix proteins.

Authors:  Mickey Pentecost; Ajay A Vashisht; Talia Lester; Tim Voros; Shannon M Beaty; Arnold Park; Yao E Wang; Tatyana E Yun; Alexander N Freiberg; James A Wohlschlegel; Benhur Lee
Journal:  PLoS Pathog       Date:  2015-03-17       Impact factor: 6.823

8.  Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.

Authors:  Simonetta Bandiera; Sophie Pernot; Hussein El Saghire; Sarah C Durand; Christine Thumann; Emilie Crouchet; Tao Ye; Isabel Fofana; Marine A Oudot; Jochen Barths; Catherine Schuster; Patrick Pessaux; Markus H Heim; Thomas F Baumert; Mirjam B Zeisel
Journal:  J Virol       Date:  2016-06-24       Impact factor: 6.549

9.  Attenuation of 40S ribosomal subunit abundance differentially affects host and HCV translation and suppresses HCV replication.

Authors:  Jing-Ying Huang; Wen-Chi Su; King-Song Jeng; Tien-Hsien Chang; Michael M C Lai
Journal:  PLoS Pathog       Date:  2012-06-28       Impact factor: 6.823

10.  Ribosomal stress and Tp53-mediated neuronal apoptosis in response to capsid protein of the Zika virus.

Authors:  Lukasz P Slomnicki; Dong-Hoon Chung; Austin Parker; Taylor Hermann; Nolan L Boyd; Michal Hetman
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.